Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer

BACKGROUND: Recently, fibroblast growth factor receptor 1 (FGFR1) was discovered in squamous cell carcinomas (SCC) of the lung with FGFR1 amplification described as a promising predictive marker for anti-FGFR inhibitor treatment. Only few data are available regarding prevalence, prognostic significa...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Cihoric, N, Savic, S, Schneider, S, Ackermann, I, Bichsel-Naef, M, Schmid, R A, Lardinois, D, Gugger, M, Bubendorf, L, Zlobec, I, Tapia, C
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2014
Teme:
Molecular Diagnostics
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4056052/
https://ncbi.nlm.nih.gov/pubmed/24853178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.229
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items